hrp0089p2-p125 | Fat, Metabolism and Obesity P2 | ESPE2018
Hamza Rasha , Elkabbany Zeinab , Kamal Tarek , Sedhom Mina
hrp0086fc3.6 | Pituitary | ESPE2016
Thomas-Teinturier Cecile , Simonin Gilbert , Vaczlavik Anna , Ajaltouni Zaina , Gaillard Stephan , Bougneres Pierre , Chanson Philippe
hrp0094p2-252 | Growth hormone and IGFs | ESPE2021
Martin-Rivada Alvaro , Campillo-Calatayud Ana , Guerra-Cantera Santiago , Sanchez-Holgado Maria , Angel Martos-Moreno Gabriel , Soriano-Guillen Leandro , Pellicer Adelina , Barrios Vicente , Argente Jesus ,
hrp0097p2-47 | GH and IGFs | ESPE2023
Soliman Ashraf , Alaaraj Nada , Rogol Alan , Alyafei Fawzia , Hamed Noor , Ahmed Shayma , Soliman Nada
hrp0089s1.3 | Recent developments in the understanding of Hypothalamo-pituitary disorders | ESPE2018
hrp0089p1-p146 | GH & IGFs P1 | ESPE2018
hrp0094gped1.1 | The use of long-acting insulin analogues in low and middle income countries | ESPE2021
hrp0086s6.1 | Prevention of childhood obesity | ESPE2016
hrp0092p2-89 | Diabetes and Insulin | ESPE2019
Rakhimova Gulnara , Sadikova Akidahon
hrp0086rfc8.1 | Growth: Clinical | ESPE2016
Bright George , Moore Wayne V. , Nguyen Huong Jil , Kletter Gad B. , Miller Bradley S. , Fechner Patricia Y. , Ng David , Humphriss Eric , Cleland Jeffrey L.